Advertisement
AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow purchase articles
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Get other permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sonder, G. J. B.
Right arrow Articles by van den Hoek, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sonder, G. J. B.
Right arrow Articles by van den Hoek, A.
Related Collections
Right arrow Community Health
Right arrow Epidemiology
Right arrow Immunization/Vaccines
Right arrow Hepatitis
Right arrow Prevention
Right arrow Public Health Practice
Hepatitis A Virus Immunity and Seroconversion Among Contacts of Acute Hepatitis A Patients in Amsterdam, 1996–2000: An Evaluation of Current Prevention Policy

Gerard J. B. Sonder, MD, MSc, Jim E. van Steenbergen, MD, PhD, Lian P. M. J. Bovee, MSc, Paul G. H. Peerbooms, PhD, Roel A. Coutinho, MD, PhD and Anneke van den Hoek, MD, PhD

Gerard J. B. Sonder, Jim E. van Steenbergen, Lian P. M. J. Bovee, Roel A. Coutinho, and Anneke van den Hoek are with the GG&GD, Department of Infectious Diseases, Municipal Health Service, Amsterdam, the Netherlands. Paul G. H. Peerbooms is with GG&GD Municipal Health Laboratory, Amsterdam. Dr. Sonder also is with LCR, National Coordination Center for Travelers Health Advice, Amsterdam. Dr. van Steenbergen also is with LCI, Coordination Communicable Disease Control, Utrecht, the Netherlands. Dr. Coutinho also is with the Academic Medical Center, University of Amsterdam.



View larger version (19K):

[in a new window]
  		FIGURE 1—— Outcomes of 1715 household contacts of 569 acute hepatitis A patients: Amsterdam, the Netherlands, January 1, 1996 through December 31, 2000.

Note. IgM = immunoglobulin M; HAV = hepatitis A virus.

(1) All reported to Municipal Health Service with jaundice and anti-HAV IgM positive.

(2) No symptoms, anti-HAV total positive; if younger than 10 years, IgM negative.

(3) All IgM positive.

(4) No symptoms and anti-HAV total negative.

(5) With symptoms and IgM positive.

(6) Without any symptoms and IgM positive. Because contacts older than 10 years who did not have symptoms were not tested, everyone in this group was aged 10 years or younger.

(7) Anti-HAV total negative in the first blood-sample, total anti-HAV positive and anti-HAV IgM positive in the sample 6 weeks later.

(8) Anti-HAV total negative in the first blood sample and in the follow-up sample 6 weeks later.

(9) IgM positive but no symptoms of any disease.

(10) IgM positive and symptoms, not always jaundice.

 




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Public Health Association